Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate

Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate - Clinical pharmacological study of [11C]S-dThd

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004319

Enrollment

Registered

2010-10-04

Start date

2010-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

[11C] S-dThd PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated cancer patients

Exclusion criteria

Exclusion criteria: - Severe heart disease (&#8805; NYHA class II) - Severe renal dysfunction - Performance Status (PS)&#8805;2; intolerable to PET scanning - Lack in ability to give an informed consent - Patients regarded as unsuitable by responsible investigators

Design outcomes

Primary

Measure	Time frame
Safety, pharmacokinetics, exposure dose, and tumor accumulation	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026